These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33202403)

  • 1. Serum Concentration and Skin Expression of S100A7 (Psoriasin) in Patients Suffering from Hidradenitis Suppurativa.
    Batycka-Baran A; Baran W; Nowicka-Suszko D; Koziol-Gałczyńska M; Bieniek A; Matusiak Ł; Łaczmański Ł; Szepietowski JC
    Dermatology; 2021; 237(5):733-739. PubMed ID: 33202403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.
    Hessam S; Gambichler T; Skrygan M; Sand M; Rüddel I; Scholl L; Bechara FG
    Eur J Dermatol; 2018 Aug; 28(4):449-456. PubMed ID: 30325321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    Inflammation; 2017 Apr; 40(2):464-472. PubMed ID: 28028756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
    Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R
    Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary alterations during the development of hidradenitis suppurativa.
    Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.
    Navrazhina K; Garcet S; Frew JW; Zheng X; Coats I; Guttman-Yassky E; Krueger JG
    J Am Acad Dermatol; 2022 Feb; 86(2):322-330. PubMed ID: 34339761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection.
    Andresen E; Lange C; Strodthoff D; Goldmann T; Fischer N; Sahly H; Branscheid D; Heine H
    BMC Pulm Med; 2011 Feb; 11():10. PubMed ID: 21324122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Global 5-Hydroxymethylation Status in Hidradenitis Suppurativa: Support for an Epigenetic Background.
    Hessam S; Sand M; Lang K; Käfferlein HU; Scholl L; Gambichler T; Skrygan M; Brüning T; Stockfleth E; Bechara FG
    Dermatology; 2017; 233(2-3):129-135. PubMed ID: 28750404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.
    Thomi R; Yerly D; Yawalkar N; Simon D; Schlapbach C; Hunger RE
    Br J Dermatol; 2017 Nov; 177(5):1358-1366. PubMed ID: 28301691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial peptides in hidradenitis suppurativa: a systematic review.
    Yao Y; Frew JW; Thomsen SF; Ring HC
    Br J Dermatol; 2022 Feb; 186(2):236-244. PubMed ID: 34498267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of psoriasin/S100A7 correlates with clinical severity in patients with oral lichen planus.
    Stolte KN; Danker K; Witt M; Ebhardt H; Dommisch H
    Clin Oral Investig; 2024 May; 28(6):318. PubMed ID: 38750317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions.
    Hessam S; Sand M; Skrygan M; Bechara FG
    Arch Dermatol Res; 2017 Sep; 309(7):557-565. PubMed ID: 28634830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
    Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
    Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCPIP1/Regnase-1 Expression in Keratinocytes of Patients with Hidradenitis Suppurativa: Preliminary Results.
    Krajewski PK; Szukała W; Lichawska-Cieślar A; Matusiak Ł; Jura J; Szepietowski JC
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
    Hessam S; Sand M; Gambichler T; Bechara FG
    J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD2 signalling in hidradenitis suppurativa.
    Gambichler T; Hessam S; Skrygan M; Bakirtzi M; Kasakovski D; Bechara FG
    Clin Exp Dermatol; 2021 Dec; 46(8):1488-1494. PubMed ID: 34056759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
    Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
    Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa.
    Jiménez-Gallo D; de la Varga-Martínez R; Ossorio-García L; Albarrán-Planelles C; Rodríguez C; Linares-Barrios M
    Mediators Inflamm; 2017; 2017():2450401. PubMed ID: 28769536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.